BSE filing, BSE: 544267. Summary written from the filing by ALFA Finder's alert engine.
Subam Papers Ltd: key numbers
- Share price
- ₹211.05
- Market cap
- ₹490.6 Cr
- Revenue (annual)
- ₹584.1 Cr
- Net profit (annual)
- ₹10.78 Cr
- P/E (TTM)
- 45.5×Sector 46.1×
- Promoter holding
- 58.93%+0.00% QoQ
- FII holding
- 0.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Subam Papers Ltd
All →Subam Papers Q2 FY27 Results: Net Loss of ₹17.8 Cr
Subam Papers Ltd reported revenue from operations of ₹200.8 Cr (+35.0% YoY) and a net loss of ₹17.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹17.8 Cr
Subam Papers Board Meeting Date
Subam Papers informed BSE that its board will meet on 12 November 2026 to approve unaudited quarter and half-year results and consider a proposed company name change. This is an advance board meeting intimation, with no decisions taken yet.
Subam Papers Other Announcement
Subam Papers Ltd filed its Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, as provided by its Registrar and Transfer Agent.
Subam Papers Annual General Meeting
Subam Papers Limited held its 22nd Annual General Meeting on September 25, 2026. Members adopted the financial statements and re-appointed directors.
Subam Papers Management Change
Subam Papers proposed appointing Mr. Arunachalam Anbu Sanjeevikani as an Independent Director for its unlisted material subsidiary, Subam Paper and Boards Private Limited.
Subam Papers Annual General Meeting
Subam Papers Limited will hold its 22nd Annual General Meeting on September 25, 2026. The meeting is scheduled for 10:30 a.m. in Tirunelveli, Tamil Nadu.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr